Dashboard
Manage Tickers

DXCMDEXCOM INC

Nasdaq dexcom.com


$ 69.81 $ -2.54 (-3.51 %)    

Wednesday, 04-Sep-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 460.65 $ -1.20 (-0.26 %)
DIA $ 410.44 $ 0.17 (0.04 %)
SPY $ 550.83 $ -1.13 (-0.2 %)
TLT $ 98.96 $ 1.26 (1.29 %)
GLD $ 230.43 $ 0.14 (0.06 %)
$ 69.82
$ 69.81 x 100
$ 69.84 x 200
-- - --
$ 62.34 - $ 142.00
4,308,057
na
27.98B
$ 1.20
$ 41.95
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-25-2024 06-30-2024 10-Q
2 04-25-2024 03-31-2024 10-Q
3 02-08-2024 12-31-2023 10-K
4 10-26-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 02-09-2023 12-31-2022 10-K
8 10-27-2022 09-30-2022 10-Q
9 07-28-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-14-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-11-2021 12-31-2020 10-K
16 10-27-2020 09-30-2020 10-Q
17 07-28-2020 06-30-2020 10-Q
18 04-28-2020 03-31-2020 10-Q
19 02-13-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 07-31-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-21-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-01-2018 06-30-2018 10-Q
26 05-02-2018 03-31-2018 10-Q
27 02-27-2018 12-31-2017 10-K
28 11-01-2017 09-30-2017 10-Q
29 08-01-2017 06-30-2017 10-Q
30 05-02-2017 03-31-2017 10-Q
31 02-28-2017 12-31-2016 10-K
32 11-01-2016 09-30-2016 10-Q
33 08-02-2016 06-30-2016 10-Q
34 04-27-2016 03-31-2016 10-Q
35 02-23-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 04-29-2015 03-31-2015 10-Q
39 02-25-2015 12-31-2014 10-K
40 11-06-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-38000-today
If You Invested $1000 In This Stock 15 Yea...
08/27/2024 18:00:14

piper-sandler-reiterates-overweight-on-dexcom-maintains-90-price-target
Piper Sandler Reiterates Overweight on Dex...
08/26/2024 16:00:38

Piper Sandler analyst Matt O'Brien reiterates DexCom (NASDAQ:DXCM) with a Overweight and maintains $90 price target.

dexcoms-stelo-device-brings-affordable-continuous-glucose-monitoring-to-type-2-diabetes-patients
Dexcom's Stelo Device Brings Affordable Co...
08/26/2024 15:39:06

DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a ...

reported-earlier-dexcom-announces-stelo-the-first-over-the-counter-glucose-biosensor-in-the-us-is-now-available-for-purchase-without-a-prescription
Reported Earlier, Dexcom Announces Stelo, ...
08/26/2024 13:22:36

Available for purchase today at Stelo.com for people in the U.S. 18 and older not using insulinProvides 24/7 powerful and perso...

decoding-18-analyst-evaluations-for-dexcom
Decoding 18 Analyst Evaluations For DexCom
08/23/2024 12:01:44

stifel-maintains-buy-on-dexcom-raises-price-target-to-100
Stifel Maintains Buy on DexCom, Raises Pri...
08/23/2024 11:27:08

Stifel analyst Mathew Blackman maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $100.

sp-500-nasdaq-100-snap-8-day-winning-streak-what-triggered-wall-streets-setback-on-tuesday
S&P 500, Nasdaq 100 Snap 8-Day Winning Str...
08/20/2024 20:39:21

S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the la...

sp-500-nasdaq-100-extend-8-session-winning-streak-as-wall-street-jitters-go-poof-mondays-key-stock-movers
S&P 500, Nasdaq 100 Extend 8-Session Winni...
08/19/2024 20:54:37

sp-500-nasdaq-100-mark-seventh-straight-positive-session-strongest-week-since-october-2023-fridays-top-movers
S&P 500, Nasdaq 100 Mark Seventh Straight ...
08/16/2024 20:09:33

S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positiv...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
08/15/2024 17:35:23

jim-cramer-this-energy-stock-is-a-buy-stay-away-from-dexcom
Jim Cramer: This Energy Stock Is A Buy, St...
08/08/2024 13:29:44

The "Mad Money" host says Dexcom had "a real bad miss... they still really haven't fully explained why that is....

heres-how-much-you-would-have-made-owning-dexcom-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
08/05/2024 21:00:24

baird-maintains-neutral-on-dexcom-raises-price-target-to-82
Baird Maintains Neutral on DexCom, Raises ...
08/05/2024 11:11:39

Baird analyst Jeff Johnson maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $80 to $82.

baird-downgrades-dexcom-to-neutral-lowers-price-target-to-80
Baird Downgrades DexCom to Neutral, Lowers...
08/05/2024 11:09:48

Baird analyst Jeff Johnson downgrades DexCom (NASDAQ:DXCM) from Outperform to Neutral and lowers the price target from $161 ...

doordash-and-exact-sciences-are-among-top-10-large-cap-gainers-last-week-july-28-aug-3-are-the-others-in-your-portfolio
DoorDash And Exact Sciences Are Among Top ...
08/04/2024 14:32:50

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, ...

jim-cramer-says-this-home-improvement-chain-is-a-buy-ahead-of-fed-rate-cut-cycle-i-would-pick-some-up-tomorrow
Jim Cramer Says This Home Improvement Chai...
07/31/2024 13:08:49

Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit fro...

top-3-health-care-stocks-that-may-explode-in-q3
Top 3 Health Care Stocks That May Explode ...
07/31/2024 11:35:49

market-momentum-your-weekly-financial-forecast
Market Momentum: Your Weekly Financial For...
07/30/2024 15:45:38

Originally published at VolumeLeaders What to expect for July 29- August 02, 2024

demystifying-dexcom-insights-from-15-analyst-reviews
Demystifying DexCom: Insights From 15 Anal...
07/29/2024 21:01:36

barclays-maintains-equal-weight-on-dexcom-lowers-price-target-to-113
Barclays Maintains Equal-Weight on DexCom,...
07/29/2024 15:58:28

Barclays analyst Matt Miksic maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and lowers the price target from $138 to $113.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION